CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −19 | $804.89 | $15K | 59,440 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −19 | $805.00 | $15K | 59,421 |
| 2023-11-13 | MURPHY ANDREW J EVP Research | Option exercise 10b5-1 | +20,000 | $270.43 | $5.4M | 79,421 |
| 2023-11-13 | MURPHY ANDREW J EVP Research | Shares withheld for taxes 10b5-1 | −13,508 | $795.69 | $10.7M | 65,913 |
| 2023-11-13 | MURPHY ANDREW J EVP Research | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −20,000 | 20,000 | ||
| 2023-11-10 | STAHL NEIL EVP Research and Development | Gift | −400 | 52,700 | ||
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −6 | $824.59 | $5K | 18,641 |
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −18 | $825.53 | $15K | 18,623 |
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −4 | $826.58 | $3K | 18,619 |
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −11 | $827.65 | $9K | 18,608 |
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −39 | $828.54 | $32K | 18,569 |
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −18 | $829.43 | $15K | 18,551 |
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −3 | $830.39 | $2K | 18,548 |
| 2023-11-07 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $838.46 | $838 | 18,547 |
| 2023-11-01 | McCourt Marion EVP Commercial | Option exercise 10b5-1 | +1,000 | $381.40 | $381K | 20,803 |
| 2023-11-01 | McCourt Marion EVP Commercial | Sale 10b5-1 | −1,000 | $783.91 | $784K | 19,803 |
| 2023-11-01 | McCourt Marion EVP Commercial | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,000 | 9,000 | ||
| 2023-10-13 | Zoghbi Huda Y Director | Option exercise 10b5-1 | +1,000 | $391.92 | $392K | 2,247 |
| 2023-10-13 | Zoghbi Huda Y Director | Sale 10b5-1 | −1,000 | $850.00 | $850K | 1,247 |
| 2023-10-13 | Zoghbi Huda Y Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,000 | 1,117 |
Page 48 of 49 · 971 trades